Insider Trading Alert - ARCP, COV, NYCB, CME And C Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Friday, Nov. 15, 2013, 163 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $60.69 to $52,812,500,000.00.

Highlighted Stocks Traded by Insiders:

American Realty Capital Properties Inc Clas (ARCP) - FREE Research Report

Schorsch Nicholas S who is Chairman of the BoD and CEO at American Realty Capital Properties Inc Clas bought 30,000 shares at $13.24 on Nov. 15, 2013. Following this transaction, the Chairman of the BoD and CEO owned 1.3 million shares meaning that the stake was reduced by 2.33% with the 30,000 share transaction.

Weil Edward M Jr. who is Pres., Treas, Secy & Dir at American Realty Capital Properties Inc Clas bought 15,000 shares at $13.24 on Nov. 15, 2013. Following this transaction, the Pres., Treas, Secy & Dir owned 121,707 shares meaning that the stake was reduced by 14.06% with the 15,000 share transaction.

The shares most recently traded at $13.22, down $0.02, or 0.17% since the insider transaction. Historical insider transactions for American Realty Capital Properties Inc Clas go as follows:

  • 12-Week # shares bought: 5,000
  • 24-Week # shares bought: 205,000

The average volume for American Realty Capital Properties Inc Clas has been 4.9 million shares per day over the past 30 days. American Realty Capital Properties Inc Clas has a market cap of $2.4 billion and is part of the financial sector and real estate industry. Shares are down 0.38% year to date as of the close of trading on Friday.

American Realty Capital Properties, Inc. owns and acquires single tenant, freestanding commercial real estate that is net leased on a medium-term basis, primarily to investment grade credit rated and other creditworthy tenants. The company principally invests in retail and office properties. The stock currently has a dividend yield of 6.9%. Currently there are 3 analysts that rate American Realty Capital Properties Inc Clas a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on ARCP - FREE

TheStreet Quant Ratings rates American Realty Capital Properties Inc Clas as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations and increase in stock price during the past year. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, poor profit margins and feeble growth in the company's earnings per share. Get the full American Realty Capital Properties Inc Clas Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Covidien (COV) - FREE Research Report

Almeida Jose E who is President and Chief Executive at Covidien sold 17,500 shares at $66.00 on Nov. 15, 2013. Following this transaction, the President and Chief Executive owned 200,566 shares meaning that the stake was reduced by 8.03% with the 17,500 share transaction.

Lannum Coleman N III who is Vice President at Covidien sold 5,707 shares at $65.49 on Nov. 15, 2013. Following this transaction, the Vice President owned 7,374 shares meaning that the stake was reduced by 43.63% with the 5,707 share transaction.

Green Eric C who is Vice President at Covidien sold 7,392 shares at $65.00 on Nov. 15, 2013. Following this transaction, the Vice President owned 12,726 shares meaning that the stake was reduced by 36.74% with the 7,392 share transaction.

Dockendorff Charles J who is EVP & Chief Financial Officer at Covidien sold 39,397 shares at $66.22 on Nov. 15, 2013. Following this transaction, the EVP & Chief Financial Officer owned 111,273 shares meaning that the stake was reduced by 26.15% with the 39,397 share transaction.

The shares most recently traded at $67.15, up $0.93, or 1.38% since the insider transaction. Historical insider transactions for Covidien go as follows:

  • 4-Week # shares sold: 39,709
  • 12-Week # shares sold: 43,149
  • 24-Week # shares sold: 59,740

The average volume for Covidien has been 2.2 million shares per day over the past 30 days. Covidien has a market cap of $30.4 billion and is part of the health care sector and health services industry. Shares are up 14.44% year to date as of the close of trading on Friday.

Covidien plc develops, manufactures, and sells healthcare products for use in clinical and home settings worldwide. The stock currently has a dividend yield of 1.96%. The company has a P/E ratio of 17.8. Currently there are 14 analysts that rate Covidien a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on COV - FREE

TheStreet Quant Ratings rates Covidien as a buy. The company's strengths can be seen in multiple areas, such as its increase in stock price during the past year and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Covidien Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

New York Community Bancorp (NYCB) - FREE Research Report

Tsimbinos John M who is Director at New York Community Bancorp sold 25,000 shares at $16.50 on Nov. 15, 2013. Following this transaction, the Director owned 275,000 shares meaning that the stake was reduced by 8.33% with the 25,000 share transaction.

The shares most recently traded at $16.46, down $0.04, or 0.24% since the insider transaction.

The average volume for New York Community Bancorp has been 2.4 million shares per day over the past 30 days. New York Community Bancorp has a market cap of $7.3 billion and is part of the financial sector and banking industry. Shares are up 26.87% year to date as of the close of trading on Friday.

New York Community Bancorp, Inc. operates as a multi-bank holding company for New York Community Bank and New York Commercial Bank that offer banking products and financial services in New York, New Jersey, Florida, Ohio, and Arizona. The stock currently has a dividend yield of 6.06%. The company has a P/E ratio of 15.5. Currently there are 3 analysts that rate New York Community Bancorp a buy, 2 analysts rate it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on NYCB - FREE

TheStreet Quant Ratings rates New York Community Bancorp as a buy. The company's strengths can be seen in multiple areas, such as its attractive valuation levels, good cash flow from operations, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full New York Community Bancorp Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

CME Group (CME) - FREE Research Report

Donaldson James A who is Director at CME Group sold 1,200 shares at $78.00 on Nov. 15, 2013. Following this transaction, the Director owned 20,093 shares meaning that the stake was reduced by 5.64% with the 1,200 share transaction.

The shares most recently traded at $79.72, up $1.72, or 2.16% since the insider transaction. Historical insider transactions for CME Group go as follows:

  • 12-Week # shares bought: 350
  • 12-Week # shares sold: 2,887
  • 24-Week # shares bought: 350
  • 24-Week # shares sold: 9,909

The average volume for CME Group has been 1.6 million shares per day over the past 30 days. CME Group has a market cap of $26.4 billion and is part of the financial sector and financial services industry. Shares are up 55.6% year to date as of the close of trading on Friday.

CME Group Inc. operates the CME, CBOT, NYMEX COMEX, and KCBT futures exchanges worldwide. It operates CBOT exchange, a marketplace for trading agricultural and the U.S. The stock currently has a dividend yield of 2.29%. The company has a P/E ratio of 27.7. Currently there are 7 analysts that rate CME Group a buy, no analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CME - FREE

TheStreet Quant Ratings rates CME Group as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, increase in net income, reasonable valuation levels and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full CME Group Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Citigroup (C) - FREE Research Report

Taylor Diana L who is Director at Citigroup sold 1,637 shares at $50.19 on Nov. 15, 2013. Following this transaction, the Director owned 8,336 shares meaning that the stake was reduced by 16.41% with the 1,637 share transaction.

The shares most recently traded at $50.74, up $0.55, or 1.08% since the insider transaction. Historical insider transactions for Citigroup go as follows:

  • 24-Week # shares sold: 45,000

The average volume for Citigroup has been 23.4 million shares per day over the past 30 days. Citigroup has a market cap of $152.3 billion and is part of the financial sector and banking industry. Shares are up 27.4% year to date as of the close of trading on Friday.

Citigroup, Inc., a diversified financial services holding company, provides a range of financial products and services to consumers, corporations, governments, and institutions worldwide. The company operates through two segments, Citicorp and Citi Holdings. The stock currently has a dividend yield of 0.08%. The company has a P/E ratio of 12.6. Currently there are 17 analysts that rate Citigroup a buy, 1 analyst rates it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on C - FREE

TheStreet Quant Ratings rates Citigroup as a buy. The company's strengths can be seen in multiple areas, such as its good cash flow from operations, notable return on equity, solid stock price performance, compelling growth in net income and attractive valuation levels. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Citigroup Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research
null

If you liked this article you might like

3 Stocks Driving The Financial Sector Higher

3 Stocks Driving The Financial Sector Higher

3 Stocks Improving Performance Of The Real Estate Industry

3 Stocks Improving Performance Of The Real Estate Industry

American Realty Capital Properties (ARCP) Stock Up After Meister Names it 'Best Idea'

American Realty Capital Properties (ARCP) Stock Up After Meister Names it 'Best Idea'

Today's Stocks Driving Success For The Real Estate Industry

Today's Stocks Driving Success For The Real Estate Industry

3 Stocks Advancing The Real Estate Industry

3 Stocks Advancing The Real Estate Industry